{"id":105324,"date":"2025-07-04T10:44:56","date_gmt":"2025-07-04T08:44:56","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/the-ccitub-and-bruker-biospin-collaborate-on-the-development-of-new-1-ghz-nmr-applications-in-the-pharmaceutical-industry\/"},"modified":"2025-07-07T08:45:48","modified_gmt":"2025-07-07T06:45:48","slug":"the-ccitub-and-bruker-biospin-collaborate-on-the-development-of-new-1-ghz-nmr-applications-in-the-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/the-ccitub-and-bruker-biospin-collaborate-on-the-development-of-new-1-ghz-nmr-applications-in-the-pharmaceutical-industry\/","title":{"rendered":"The CCiTUB and Bruker BioSpin collaborate on the development of new 1 GHz NMR applications in the pharmaceutical industry"},"content":{"rendered":"

The Scientific and Technological Centers of the University of Barcelona (CCiTUB<\/a>), located at the Barcelona Science Park, and Bruker BioSpin<\/a> have signed a collaboration agreement for the optimization of the 1.0 GHz nuclear magnetic resonance (NMR) equipment. The agreement aims to explore the potential of 1.0 GHz NMR systems for the characterization of biologic products of therapeutic interest to the pharmaceutical industry, such as full antibodies (MW 150 kDa) and RNA\/DNA fragments (approximately 20 to 80 nucleotides).<\/strong><\/p>\n

The CCiTUB and Bruker BioSpin will work together to analyze these products, primarily sourced from pharmaceutical companies that are collaborators. This opportunity will allow companies to analyze their compounds with high-field NMRs accurately and efficiently, benefiting from the comprehensive knowledge provided by the joint work of the scientific-technical staff of the NMR laboratory at CCiTUB and the manufacturer of this unique equipment.<\/p>\n

The 1GHz equipment, unique in Europe<\/strong><\/h3>\n

The 1.0 GHz (23.5 T) Nuclear Magnetic Resonance Spectrometer was acquired by the CCiTUB in March 2023 thanks to a grant from the Ministry of Science and Innovation and the NextGeneration EU funds within the Recovery, Transformation and Resilience Program.<\/p>\n

The acquisition of this equipment has made it a unique asset in its field and has had a direct impact on Catalonia\u2019s industry, particularly in key sectors like biomedical and biotechnological. The equipment\u2019s high resolution and sensitivity provide a significant impetus for the structural and dynamic study of complex biomolecules.<\/p>\n